Patient-Reported Social Impact of Molecularly Confirmed Retinitis Pigmentosa
- PMID: 40364260
- PMCID: PMC12072349
- DOI: 10.3390/jcm14093229
Patient-Reported Social Impact of Molecularly Confirmed Retinitis Pigmentosa
Abstract
Objectives: To evaluate the patient-reported impact of retinitis pigmentosa (RP) in a large patient cohort to identify relevant disease-related disadvantages as key aspects for the improvement of ophthalmic and social care. Methods: Consecutive patients with molecularly confirmed RP older than 18 years of age were identified in two tertiary care centers in Germany. Patients were contacted to participate in an anonymized patient query regarding the impact of RP on their vocational training, professional career, and social, familial, and personal life, as well as their experience with ophthalmologic care. Results: Out of 241 contacted patients, 162 responded (67.2%; 52.5% female, 67.3% younger than 50 years of age). While the impact of RP on vocational training was limited, professional careers were frequently disrupted with early retirement rates of 39.8% (≥40 years of age) to 50% (≥50 years of age). Most respondents felt restricted in their participation in public life (66.3%). One-fifth complained about financial restrictions; however, one-third of this number did not obtain financial help. A negative impact on familial life (21.4%) was less frequently reported compared to personal impairments, especially anxiety (74.5%) and depression (24.2%). Most respondents considered their ophthalmic care as adequate; however, a delayed diagnosis (≥two years: 28.6%) and initial misdiagnosis (24.0%) were frequent. Insufficient psychological support was the major complaint about professional care. Conclusions: RP affects the lives of patients in multiple aspects. Ophthalmic and social care providers should focus on the acceleration of the diagnostic process, as well as easy access to financial assistance and psychological support, as key areas for improvement. Improvements in these areas are expected to reduce challenges for patients. They should have an impact on rehabilitation, participation in public life, and quality of life.
Keywords: anxiety; financial burden; ophthalmologic care; patient-reported impact; quality of life; retinitis pigmentosa; social care.
Conflict of interest statement
Authors B. Lindau and U. Kellner were employed by MVZ Augenärztliches Diagnostik- und Therapiecentrum Siegburg GmbH. G. Spital: Honoraria for lectures: Bayer Vital GmbH, Germany; Novartis Germany; Roche GmbH, Germany. Monitoring/Advisory boards: Bayer Vital GmbH, Germany; Novartis GmbH Germany; Roche GmbH, Germany, Stada GmbH, Germany. U. Kellner: Honoraria for lectures: Abbvie GmbH, Germany; Apellis GmbH, Germany; Bayer Vital GmbH, Germany; Heidelberg Engineering GmbH, Germany; Novartis Germany. Monitoring/Advisory boards: Apellis GmbH, Germany; Astellas GmbH, Germany; Bayer Vital GmbH, Germany; Chiesi GmbH, Germany; Novartis GmbH Germany; Rhythm Pharmaceuticals Germany GmbH, Roche GmbH, Germany; Sandoz/Hexal AG, Germany. Board Member: Member of the Scientific Board of Pro Retina Germany e.V. The remaining authors N. Zehe-Lindau, H. Stöhr and B.H.F. Weber declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
[Social ophthalmologic aspects of retinitis pigmentosa].Ophthalmologe. 1995 Oct;92(5):704-7. Ophthalmologe. 1995. PMID: 8751001 German.
-
Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. PMID: 28876770 Free Books & Documents. Review.
-
The Burden of X-Linked Retinitis Pigmentosa on Patients and Society: A Narrative Literature Review.Clinicoecon Outcomes Res. 2021 Jun 23;13:565-572. doi: 10.2147/CEOR.S297287. eCollection 2021. Clinicoecon Outcomes Res. 2021. PMID: 34188501 Free PMC article. Review.
-
Prevalence of Retinitis Pigmentosa in a Tertiary Eye Hospital of Nepal.Nepal J Ophthalmol. 2022 Jan;14(27):31-38. doi: 10.3126/nepjoph.v14i1.38977. Nepal J Ophthalmol. 2022. PMID: 35996901
-
Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs.Clin Ophthalmol. 2022 Jun 20;16:1993-2010. doi: 10.2147/OPTH.S365486. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35757022 Free PMC article.
References
-
- Bunce C., Zekite A., Wormald R., Bowman R. Is there evidence that the yearly numbers of children newly certified with sight impairment in England and Wales has increased between 1999/2000 and 2014/2015? A cross-sectional study. BMJ Open. 2017;7:e016888. doi: 10.1136/bmjopen-2017-016888. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources